In accordance with results observed with HMGB1 silencing using shRNA, systemic treatment of tumour-bearing mice with the HMGB1 inhibitor BoxA also resulted in significantly delayed tumour growth compared to mice exposed to vehicle alone (Fig. 4b). The gene discussed is HMGB1; the disease is neoplasm.